Polymerase-Linked Nucleotides for Low-Cost, Accurate Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current sequencing technologies for nucleic acids are prohibitively expensive for widespread deployment across large populations, hindering genetic correlation studies and individualized healthcare applications.

Innovation Solution

Development of polymerase-linked nucleotides covalently attached to a catalytically active polymerase enzyme via a flexible linker, allowing non-covalent binding at the active site and incorporation into polynucleotides, with a detectable label for sequencing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional sequencing platforms are used, then sequencing accuracy is maintained, but cost becomes prohibitively expensive for large-scale deployment

Engineering Contradiction:
Improvesequencing accuracyVSAvoidcost per sequence
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent combines the polymerase enzyme, nucleotide, and detectable label into a single conjugated entity. This merging eliminates the need for separate reagent additions and reduces the number of chemical components required, directly lowering material costs while maintaining sequencing accuracy through the integrated design.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The polymerase-conjugate serves multiple functions simultaneously: it acts as the catalytic enzyme for nucleotide incorporation, provides the detectable signal for base identification, and enables single-step reaction chemistry. This multi-functionality reduces the total number of reagents needed, decreasing cost per sequence while preserving reliability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Productivity

If reagent volume is reduced for cost-effectiveness, then scalability improves, but detection sensitivity may be compromised

Engineering Contradiction:
Improvethroughput and scalabilityVSAvoiddetection sensitivity
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

By merging the detectable label directly onto the polymerase-nucleotide conjugate, the invention ensures that every enzymatic event produces a detectable signal. This integration maintains high detection sensitivity even in reduced reaction volumes because the signal source is concentrated at the reaction site rather than distributed in bulk solution.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The flexible linker acts as an intermediary between the polymerase active site and the detectable label, positioning the label optimally for detection while allowing the polymerase to function normally. This mediator ensures that signal generation is not compromised by the reduced reagent volumes used in high-throughput applications.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If multiple separate reagents are used for nucleotide incorporation, then catalytic activity is maintained, but reaction complexity and error rates increase

Engineering Contradiction:
Improvenucleotide incorporation accuracyVSAvoidreaction protocol complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges the polymerase, nucleotide substrate, and detectable label into a single conjugated reagent. This eliminates the need for separate addition steps and reduces protocol complexity while maintaining incorporation accuracy because the nucleotide is pre-positioned on the enzyme with correct stereochemistry and bonding.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The nucleotide is pre-attached to the polymerase with the correct spatial orientation and chemical bonding before the sequencing reaction begins. This preliminary action ensures that the nucleotide will be transferred accurately to the growing DNA strand, reducing errors from improper positioning or incomplete reactions that can occur with separate reagent additions.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables cost-effective, high-throughput sequencing by reducing reagent use and reaction volume, while enhancing detection accuracy through dwell time monitoring and minimizing errors, facilitating large-scale genetic studies and personalized healthcare.

Implementation Method 1

a nucleotide covalently attached to a catalytically active polymerase enzyme by a flexible linker

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

the linker attachment to the nucleotide allows the nucleotide to bind non-covalently at the active site of the polymerase

Methodology Applied
Scientific EffectNon-covalent binding: Adsorption

Data Source

PatentUS12351868B2Enzyme-linked nucleotides
Publication Date: 2025.07.08 ILLUMINA INC
  • US12351868B2 patent drawing
  • US12351868B2 patent drawing
  • US12351868B2 patent drawing

AI summary

Presented herein are polymerase-linked nucleotides for improved distinguishing nucleotide sequences for different nucleic acid molecules. Also presented are methods and systems using the polymerase-linked nucleotides for improved distinguishing nucleotide sequences for different nucleic acid molecules.